Home > Newsletters > Drug Industry Daily > FDA Study May Help Sponsors Identify Potential for Serious Drug Reactions Sooner
Drug Industry Daily
May 24, 2012 | Vol. 11 No. 103
FDA Study May Help Sponsors Identify Potential for Serious Drug Reactions Sooner
CDER’s discovery of an autoimmune mechanism that leads to serious drug-induced adverse reactions in some patients taking HIV drug Ziagen could give drugmakers new methods to more quickly identify a drugs’ potential to cause severe reactions.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.